Jones R N, Gerlach E H, Koontz F P, Murray P R, Pfaller M A, Washington J A, Erwin M E, Knapp C C
University of Iowa College of Medicine, Iowa City.
J Clin Microbiol. 1991 Feb;29(2):363-6. doi: 10.1128/jcm.29.2.363-366.1991.
Cefotetan was tested in a multilaboratory study to standardize susceptibility testing criteria and quality control guidelines for Neisseria gonorrhoeae. Cefotetan was most active against penicillinase-producing and penicillin-susceptible strains (MIC for 50% of strains tested, 0.5 micrograms/ml) and was least active against the chromosomally resistant isolates (MIC for 50% of strains tested, 2 micrograms/ml). The recommended 30-micrograms disk cefotetan interpretive criteria were as follows: susceptible at greater than or equal to 26 mm (less than or equal to 2 micrograms/ml), intermediate at 20 to 25 mm (4 micrograms/ml), and resistant at less than or equal to 19 mm (greater than or equal to 8 micrograms/ml). Quality control guidelines for agar dilution and disk diffusion tests were established by using numerous GC agar lots, three cefotetan 30-micrograms disk lots, two quality control organisms, and a volume of tests consistent with National Committee for Clinical Laboratory Standards M23-T guidelines.
在一项多实验室研究中对头孢替坦进行了测试,以规范淋病奈瑟菌药敏试验标准和质量控制指南。头孢替坦对产青霉素酶菌株和对青霉素敏感的菌株活性最强(50%受试菌株的MIC为0.5微克/毫升),而对染色体耐药分离株活性最弱(50%受试菌株的MIC为2微克/毫升)。推荐的30微克头孢替坦纸片的解释标准如下:大于或等于26毫米为敏感(小于或等于2微克/毫升),20至25毫米为中介(4微克/毫升),小于或等于19毫米为耐药(大于或等于8微克/毫升)。通过使用大量的GC琼脂批次、三批30微克头孢替坦纸片、两种质量控制菌以及符合美国国家临床实验室标准委员会M23-T指南的测试量,确立了琼脂稀释法和纸片扩散法的质量控制指南。